2024-05-01 16:07:10 ET
Surmodics, Inc. (SRDX)
Q2 2024 Earnings Conference Call
May 1, 2024 08:00 ET
Company Participants
Gary Maharaj - President and Chief Executive Officer
Timothy Arens - Chief Financial Officer
Conference Call Participants
Brooks O’Neil - Lake Street Capital Markets
Joseph Conway - Needham & Company
Jim Sidoti - Sidoti & Company
Mike Petusky - Barrington Research
Presentation
Operator
Welcome everyone to Surmodics’ Second Quarter of Fiscal Year 2024 Earnings Call. Please note that this call is being webcast the webcast accessible through Investor Relations section of the Surmodics website at www.surmodics.com, where an audio replay will be archived for future reference. An earnings press release disclosing Surmodics quarterly and full year results was issued earlier today and is available on the company website as well.
Before we begin, I would like to remind everyone that remarks in response to your questions on today’s call may contain forward-looking statements. These forward-looking statements are covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include statements regarding Surmodics’ future financial and operating results or other statements that are not historical facts.
Please be advised that actual results could differ materially from those stated or implied by Surmodics forward-looking statements resulting from certain risks and uncertainties, including those described in the company’s SEC filings. Surmodics disclaims any duty to update or revise these forward-looking statements as a result of new information, future events, developments or otherwise. This call will also include references to non-GAAP measures because Surmodics believes they provide useful information for investors. Today’s earnings release contains reconciliation tables to GAAP results.
I would now like to turn the call over to Mr. Gary Maharaj, Surmodics’ President and Chief Executive Officer. Please go ahead, sir.
Gary Maharaj
Thank you, Kat, and welcome, everyone, to our second quarter fiscal year 2024 earnings call. Let me provide you with a brief overview of what we plan to cover today. I will review our quarterly financial performance at a high level and discuss the operational progress we’ve made with respect to our key strategic objectives for fiscal 2024. Tim will then walk through our financial results in further detail and review our financial guidance, which we updated in our earnings press release earlier this morning. I’ll then share some concluding thoughts on our outlook before opening the call for questions. ....
Read the full article on Seeking Alpha
For further details see:
Surmodics, Inc. (SRDX) Q2 2024 Earnings Call Transcript